Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Endoscopic Procedures V: ERCP01:26

Endoscopic Procedures V: ERCP

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional Outcome of High Tibial Osteotomy and Type-II Undenatured Collagen in Active Middle-Aged Adults in Early Knee Osteoarthritis: A Prospective Comparative Study.

Cureus·2025
Same author

Healthcare and cutting-edge technology: Advancements, challenges, and future prospects.

Computers in biology and medicine·2025
Same author

Obesity Management Medications as Adjuncts to Metabolic and Bariatric Surgery: Consensus Recommendations from India.

Obesity surgery·2025
Same author

Metastatic pancreatic cancer now in remission: a case report and literature review.

Discover oncology·2025
Same author

Gastroduodenal artery aneurysm degeneration after coiling necessitating open repair.

Journal of vascular surgery cases and innovative techniques·2025
Same author

Preoperative Chemotherapy Does Not Impact Failure to Rescue in Patients Undergoing Pancreatectomy.

The Journal of surgical research·2024

Related Experiment Video

Updated: May 28, 2026

Laparoscopic Common Bile Duct Exploration Followed by Primary Suture Using a Modified Bile Duct Incision
05:36

Laparoscopic Common Bile Duct Exploration Followed by Primary Suture Using a Modified Bile Duct Incision

Published on: May 2, 2025

Biliary dyskinesia: how effective is cholecystectomy?

Vikas Singhal1, Patrick Szeto, Heather Norman

  • 1Department of Surgery, Guthrie-Robert Packer Hospital, 1 Guthrie Sq, Sayre, 18840, PA, USA. singhalvik@gmail.com

Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|November 2, 2011
PubMed
Summary

Cholecystectomy for biliary dyskinesia shows limited long-term effectiveness, with over 40% experiencing persistent symptoms. Pathologic inflammation was the only factor predicting symptom resolution after surgery.

Related Experiment Videos

Last Updated: May 28, 2026

Laparoscopic Common Bile Duct Exploration Followed by Primary Suture Using a Modified Bile Duct Incision
05:36

Laparoscopic Common Bile Duct Exploration Followed by Primary Suture Using a Modified Bile Duct Incision

Published on: May 2, 2025

Area of Science:

  • Gastroenterology
  • Surgical Outcomes
  • Biliary System Disorders

Background:

  • Biliary dyskinesia management often relies on short-term surgical follow-up.
  • Patients with persistent symptoms are frequently managed by primary care providers and gastroenterologists post-discharge.

Purpose of the Study:

  • To analyze long-term outcomes of cholecystectomy for biliary dyskinesia.
  • To identify factors predicting patient benefit from cholecystectomy.

Main Methods:

  • Retrospective analysis of medical records for patients undergoing cholecystectomy for biliary dyskinesia (2001-2010).
  • Minimum 6-month postoperative follow-up evaluated.

Main Results:

  • 13.4% reported persistent symptoms at initial surgical follow-up.
  • 43.3% with persistent/recurrent symptoms were seen by primary care providers.
  • Pathologic inflammation was the sole predictor of symptom resolution (p=0.02).

Conclusions:

  • Cholecystectomy's effectiveness for biliary dyskinesia is questionable with long-term follow-up.
  • Symptom resolution is significantly linked to the presence of inflammation in surgical pathology reports.